Shanghai, China

Cheng Ni

This inventor holds 39 USPTO granted patents and 34 published patent applications and 3 EPO patents, primarily in Radiation Therapy. Top assignees: Shanghai United Imaging Healthcare Co., Ltd., Shanghai United Imaging Healthcare Ltd.. Active years: 2017-2026.

USPTO Granted Patents = 39 

% Patents Active = 97.4

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Radiation Therapy
X-ray Imaging
Multileaf Collimator
Imaging System
Radiotherapy Device
Electron Beam Control
Radiation Treatment Plan
Image-Guided Surgery
Superconducting Magnet
Therapeutic Apparatus
Heat Exchange
Calibration
39 patents (USPTO):Explore Patents

Title: The Innovative Journey of Cheng Ni

Introduction: Cheng Ni, a pioneering inventor hailing from Shanghai, CN, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Cheng Ni's latest patents include advancements in artificial intelligence algorithms for autonomous vehicles, wearable health monitoring devices, and sustainable energy solutions.

Career Highlights: With a career spanning over two decades, Cheng Ni has worked with leading tech companies in Shanghai, CN, focusing on research and development in emerging technologies. His expertise lies in the intersection of software engineering and hardware design, leading to the creation of cutting-edge products.

Collaborations: Cheng Ni has collaborated with renowned research institutions and universities globally to further his inventions. His partnerships have resulted in the successful development of patented technologies that have revolutionized various industries.

Conclusion: Cheng Ni's relentless pursuit of innovation and his passion for creating transformative technologies continue to inspire the next generation of inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…